Terence R. Flotte, M.D.

Secretary


Terence R. Flotte, M.D. is the provost and executive deputy chancellor of the University of Massachusetts Medical School and has been an ASGCT member since the Society's founding and committee participant on the Respiratory Disease Committee and as chair of previous iterations of both the Clinical and Regulatory Affairs Committee, and the Advisory Council. He will assume the role of secretary with ASGCT, and will be instrumental in developing the program for upcoming ASGCT Annual Meetings.

Flotte's research investigates delivery of therapeutic genes and miRNA with recombinant AAV vectors for monogenic diseases, such as alpha-1 antitrypsin (AAT) deficiency and cystic fibrosis (CF). In 1995, his lab was the first to use recombinant adeno-associated virus (rAAV) in humans when they conducted CF clinical trials.

2019
ASGCT Policy Summit
November 4 – 6 | Washington D.C.
Close